Fulcrum Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Fulcrum Therapeutics, Inc. has filed 513 SEC EDGAR filings since 25 Jul 2016

SEC filing history

Showing 251-275 of 513 matching filings.

Per page
25
Current page
11
4

FORM 4 SUBMISSION

Filing date
19 Jul 2022
Reporting date
15 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2022
Reporting date
27 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91080

SCHEDULE 13G

Filing date
22 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Jun 2022
Reporting date
07 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 May 2022
Reporting date
06 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-260754

424B5

Filing date
10 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-260754

POS EX

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260754

EFFECT filing

Filing date
28 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38978

DEFA14A

Filing date
28 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38978

DEF 14A

Filing date
28 Apr 2022
Reporting date
08 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Apr 2022
Reporting date
07 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .